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ABSTRACT 
Obesity causes chronic inflammatory reaction is characterized by elevated levels of high sensitivity c-reactive protein 
(hscrp). Hscrp and hdl could be used as an early marker of cardiovascular disease risk. Tempeh gembus contain fiber, 
unsaturated fatty acids and antioxidants, which can reduce the inflammatory reaction. This study determines the effect of 
processed Tempeh gembus on hsCRP and HDL in obese women. This study included in experimental studies with 
randomized post-test only control group design involving 40 obese women aged 20 – 50 years. Subjects were randomized 
into two groups: a control group was given a standard diet low in calories 30 calories/kg body weight, and the treatment 
group was given a standard diet low in calories 30 calories/kg body weight and Tempeh gembus for 28 days. hsCRP and 
HDL levels were measured before and after the intervention, food intake was measured by using a 3 x 24-hour recall and 
physical activity (IPAQ form). HsCRP levels were measured using the ELISA method, whereas HDL levels were measured 
using the CHOD-PAP method. Wilcoxon test (hsCRP levels) and paired t-test (HDL levels) used to test differeces before 
and after intervention each group. Mann Whitney test (hsCRP levels) and independent sample test (HDL levels) used to test 
differeces before and after intervention between groups. There are differences in hsCRP levels before and after the 
intervention in the control group (p = 0.00) and the treatment group (p = 0.00). There are differences in HDL levels before 
and after the intervention in the control group (p = 0.00) and the treatment group (p = 0.00). There are differences in the 
decrease hsCRP levels between the two groups (p = 0.00). There are differences in the increase in HDL levels between the 
two groups (p = 0.03). Tempeh gembus 150 grams/day can decrease hsCRP levels and increase HDL levels in women with 
obesity. 
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INTRODUCTION 
 Obesity is excessive fat accumulation due to an 
imbalance between energy intake and energy released by 
the body so that it can interfere with health (WHO, 2016). 
Obesity is the cause of half the cases of hypertension that 
increases the risk of cardiovascular disease (Sizer and 
Whitney, 2017). Cardiovascular disease is caused by 
narrowing, blockage of coronary arteries and reduced 
elasticity of blood vessels due to atherosclerosis 
(Herrington et al., 2016). Atherosclerosis is a progressive 
disease, even estimated to have occurred since the age of 
10 – 20 years with the formation of fat streaks walking 
slowly and continues to grow by 3% per year since past 
the age of 20 years. Atherosclerosis occurs due to the 
interaction of various risk factors, including obesity, 
hypertension, diabetes mellitus, smoking habits, the aging 
process, atherogenic dyslipidemia, and pro-inflammatory 
conditions (Badimon, Robert and Gemma, 2011).  
 Obesity can also lead to the occurrence of the reaction 
inflammation due to their secretion of cytokines and pro-
inflamator (Harford et al., 2011). Inflammatory reactions 
cause damage to endothelial function resulting in an 
increase in  stroke volume and cardiac output. Excessive 
adipose tissue causing chronic inflammatory reactions due 
to cytokine secretion and proinflamator by adipocyte cells 
are characterized by increased levels of high sensitivity  
C-reactive protein (hsCRP), Tumor Necrosis Factor (TNF-
α), interferon-gamma (IFN γ) and interleukin-6 (IL-6) 
(Guillen et al., 2008; Libby, Ridker and Maseri, 2002). 
hsCRP is a biomarker that is sensitive to the occurrence of 
inflammation in the body and is a strong predictor of the 
incidence of cardiovascular system disease (Tully et al., 
2015). Increased levels of hsCRP in the long term 
indicates a process of chronic inflammation (Pravin and 
Devang, 2011).  
 Increased adipose tissue in obesity is closely related to 
the consumption habits of foods that are high in fat and 
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low in fiber. Excessive fat intake will affect adipose tissue 
especially visceral fat to express responses to various 
stimuli, one of which is an increase in the release of free 
fatty acids by adipose tissue which can stimulate increased 
secretion of very low density lipoprotein (VLDL) in the 
liver which in turn results in increased triglycerides, low 
density lipoprotein (LDL), and decreased high density 
lipoprotein (HDL) (Wang and Peng, 2011). Low HDL 
levels are not able to prevent the activation of pro-
inflammatory mediators in the form of cytokines such as 
TNF-α, IL-6 and CRP. The results showed that subjects 
with HDL levels greater than 60 mg/dL had a lower risk of 
developing coronary heart disease because an increase of 1 
mg/dL HDL levels could reduce the risk of coronary heart 
disease by 2% in men and 3% in women (Rajagopal, 
Suresh and Alok, 2012).  
 Prevention and management of cardiovascular disease 
can be done by optimizing the consumption of functional 
foods with high protein fermented foods that are suspected 
to be able to prevent cardiovascular disease (Bowen et al., 
2018; Anand et al., 2016). Tempeh gembus is one of 
Indonesia's original food products made from fermented 
tofu-based fermentation that functions as a substrate then 
the tempeh mushroom (Rhizopus oligosporus) is added as 
a microorganism. The main content of Tempeh gembus is 
fiber. The fiber content in 100 grams of Tempeh gembus is 
3.93 grams, three times more than the fiber content in 
soybean Tempeh (Sulchan and Endang, 2007; Li, Qiao 
and Lu, 2012). High-fiber diet (≥25 grams of soluble fiber 
and ≥47 grams of insoluble fiber) per day can reduce the 
risk by up to 50% of stroke in the population (Casiglia et 
al., 2013). Other research shows that the Tempeh gembus 
which is processed into snacks, namely Kerupuk Gembus 
contains quite high fiber as much as 54.4 – 67.4% (Afifah 
et al., 2019a). The fiber content in tempeh gembus has 
anti-inflammatory, anti-carcinogenic effects, can reduce 
gastrointestinal transit time which is good for treating 
diarrhea and constipation (Gropper, Smith, and Groff, 
2012). Fresh Tempeh gembus contains 1.87% fat, 11.09% 
fiber, 4.90% protein, 89.67% protein digestibility, 14.03% 
amino acids, 48.07% antioxidant activity, 0.05% genistein, 
and 0.07% daidzein (Afifah et al., 2019b). In addition 
Tempeh gembus also contains unsaturated fatty acids 
linoleic acid (21.51%), linolenic aid (1.82%) and oleic 
(16.72%) (Sulchan and Endang 2007; Sulchan and 
Rukmi 2007). Damanik et al. (2018) showed that the 
saturated fatty acid content in Tempeh gembus (12.55%) 
was higher than the saturated fatty acid in soybean 
(12.01%) and tofu residue (12.41%). The content of oleic 
acid in Tempeh gembus can suppress the production of 
pro-inflammatory cytokines. Giving Tempeh gembus in 
rats fed atherogenic diet can reduce hsCRP levels (Dewi et 
al., 2018). Research conducted by Noviana et al. (2018) 
on Tempeh gembus hydrolyzate which was given 5000 
ppm and 8000 ppm bromelin enzymes were able to 
prevent the microbial activity of S. aureus, B. subtilis, and 
S. mutans. Tempeh gembus also contains fibrinolytic 
protease-producing microbes, namely Bacillus pumilus 2 g 
(AB968524). Pure fibrinolytic enzymes from Bacillus 
pumilus 2 g are included in the serine protease group of 
subtilin which can degrade the α and β chains of 
fibrinogen quickly so that it has the potential to prevent 
cardiovascular (Afifah et al., 2014). Tempeh gembus has 
also been shown to reduce oxidative stress. Giving Tempeh 
as much as 25 g.kg-1 of Sprague Dawley rats for 28 days 
on an atherogenic diet, can reduce levels of malonaldehyde 
and homocysteine. A significant decrease occurred in the 
administration of fresh Tempeh gembus and gembe 
gembus which were given bromelain enzyme  
25 ppm (Kurniasari et al., 2017). Giving Tempeh gembus 
with a dose of 8% and 12% for 5 weeks in experimental 
animals showed a decrease in levels of total cholesterol, 
LDL cholesterol and increased HDL (Afifah et al., 2014).  
 
Scientific hypothesis  
 We investigate several hypotheses in our study: 
a. Provision of processed Tempeh gembus affects the 
decrease in levels of high sensitivity c-reactive protein 
(hsCRP),   
b. Provision of processed Tempeh gembus has an effect 
on increasing levels of high density lipoprotein (HDL).  
 
MATERIAL AND METHODOLOGY 
 This study is a true experimental study using a pre-post 
randomized control group design (Sastroasmoro and 
Ismael, 2011). Subjects were divided into two groups, 
namely the control group and the treatment group. The 
independent variable of this study was the administration 
of 150 grams of processed Tempeh gembus for 28 days 
while the dependent variable was the levels of hsCRP and 
HDL. Researchers have obtained Ethical Clearance from 
the Ethics Commission of the Faculty of Medicine at 
Sultan Agung University Semarang, Indonesia with 
number 33/I/2019/Bioethics Commission.  
 The study was conducted in March 2019 on 40 female 
prisoners of Class II Penitentiary in the City of Semarang. 
Subject retrieval is done based on inclusion criteria, 
namely women aged 20-50 years, body mass index ≥23 
kg.m-2 , do not have a history or are undergoing liver 
disease, kidney, cancer, coronary heart disease, stroke, do 
not smoke, are willing to participate in this study by 
signing an informed consent .  
 Physical activity level data were obtained through direct 
interviews using the IPAQ form and then calculated using 
the Physical Activity Level (PAL) formula (WHO, 2011).  
Categorizing the level of physical activity is light  
(1.40 – 1.69 units), moderate (1.70 – 1.99 units), and 
heavy (2.00 – 2.40 units). Data on Body Mass Index were 
obtained based on measurements of body weight and 
height. Data on nutrient intake was obtained through direct 
interviews using a food recall form and then analyzed 
using Nutrisurvey software. 
 Determination of the subject of this study using 
consecutive sampling method, and found as many as 73 
people were willing to have blood drawn for the initial 
screening process. There were 40 subjects who met the 
inclusion criteria which were then divided into 2 groups: 
one control group and one treatment group with each 
group consisting of 20 subjects. The control group was 
given a diet limiting the intake of 30 calories/kg body 
weight/day while the treatment group as many as  
20 people were given a dietary intake limiting the intake of 
30 calories/kg body weight/day + processed 150 grams of 
Tempeh gembus/day. 
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Food intake restriction intervention is done by reducing 
food portions while still paying attention
to the nutritional value (Redman and Ravussin, 2011). 
Limitation of food intake is given in stages as much as  
30 kcal.kg-1 body weight/day through food menus 
provided by the correctional institution which refers to a 
low calorie diet for obesity by considering the gender and 
physical activity of the subject (Wahyuningsih, 2013). 
The Japan Atherosclerosis Society (JAS) recommends 
limiting food intake for obese subjects with mild physical 
activity levels of 25 – 30 kcal.kg-1 body weight  day,  
30 – 35 kcal.kg-1 body weight/day for subjects with 
moderate physical activity levels and >35 kcal.kg-1 body 
weight/day for subjects with heavy levels of physical 
activity (Kinoshita et al., 2017). Interventions in the two 
groups were carried out for 28 days.  
 The independent variable of this study was the 
administration of 150 grams of processed Tempeh gembus. 
Tempeh gembus which will be given as treatment material 
is made by researchers and the team, in the Laboratory of 
Food Technology laboratory polytechnic health of 
Semarang using tofu waste obtained from tofu craftsmen 
in the Cinde-Lamper region of Semarang City, Tempeh 
yeast used is Raprima yeast. Tempeh gembus is processed 
into 5 types of cuisine, namely: bacem, satay, oseng, 
pepes, and balado. 
The dependent variable of this study is the levels of hsCRP 
and HDL. HsCRP levels were measured using the Enzyme 
Linked Immunosorbent Assay (ELISA) method 
(Crowther, 2009). Whereas HDL levels were measured 
by laboratory workers using the Cholesterol Oxidase-
Peroxidase Aminoantipyrine Phenol (CHOD-PAP) method 
(McPherson and Pincus, 2016). Blood samples were 
taken by Semarang CITO Laboratory officials twice, 
namely on the first day before being given an intervention 
and 1 day after the intervention (the 29th day).   
 
Statistic analysis   
 Data were analyzed using the version 16.0 of Statistical 
Package for the Social Sciences (SPSS). Differences in 
hsCRP levels before and after treatment were analyzed 
using the Wilcoxon test because the data were not 
              
 Figure 1 Tofu waste fresh.            Figure 2 Preparation of Tempeh Gembus.     Figure 3 Addition Tempeh yeast. 
 
             
 Figure 4 Tempeh Gembus has been          Figure 5 Tempeh Gembus Balado.              Figure 6 Tempeh Gembus Oseng.   
ermented for 36 hours. 
 
             
Figure 7 Tempeh Gembus Bacem.             Figure 8 Tempeh Gembus Pepes.              Figure 9 Tempeh Gembus Satay. 
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normally distributed. Differences in treatment effect 
between the two groups were analyzed using the Mann 
Whitney test. Differences in HDL levels before and after 
treatment were analyzed using paired t-test because the 
data were normally distributed. Differences in treatment 
effect between the two groups were analyzed using the 
independent sample test.  
 
RESULTS AND DISCUSSION 
 Subject characteristics consisting of age, level of physical 
activity, Body Mass Index before and after treatment are 
presented in Table 1. All subjects in the study were in the 
age group of 21-50 years. The mean age in the control 
group (35.05 ±8.54 years) was lower than in the treatment 
group (36.50 ±9.37 years). The Mann Whitney test showed 
that there was no significant difference in age between 
groups (p = 0.64), so age was not a confounding variable 
in the study. The mean level of physical activity during the 
study in the control group (1.52 ±0.17 units) was higher 
than the treatment group (1.48 ±0.10 units). The Mann 
Whitney test showed that there was no difference in the 
average level of physical activity between groups  
(p = 0.84), so the level of physical activity was not a 
confounding variable in the study. Based on WHO (2011), 
the level of subject activity in this study was included in 
the mild category (1.40 – 1.69 unit).  
Table 1 also shows that the average Body Mass Index 
(BMI) before and after the study in the control group 
(30.00 ±5.61 kg.m-2; 29.63 ±5.42 kg.m-2)  than the 
treatment group (28.22 ±2.49 kg.m-2; 27.32 ±2.50 kg.m-2). 
The Mann Whitney test showed that there was no 
difference in mean Body Mass Index before (p = 0.51) and 
after research (p = 0.16),  confounding in the study.  
 Table 2 shows data on energy, protein, fat and 
carbohydrate intake patterns before the study. The mean 
energy intake before the study in the control group 
(2306.96 ±545.24 kcal) was higher than in the treatment 
group (2057.70 ±241.06 kcal), the Mann Whitney test 
showed that there were significant differences in energy 
intake between groups (p = 0.01) so that energy intake 
before the study becomes confounding variable. The mean 
protein intake before the study in the control group  
(84.86 ±19.08 grams)  was higher than the treatment group 
(72.59 ±19.16 grams), the independent sample test showed 
that there were significant differences in energy intake 
between groups (p = 0.04) so that protein intake before it 
can become confounding variables. The mean fat intake 
before the study in the control group (86.8 ±31.84 grams) 
was higher than the treatment group (60.57 ±18.75 grams), 
the independent sample test showed that there were 
significant differences in energy intake between groups  
(p = 0.00) so that fat intake before the study can be a 
confounding variable. The mean carbohydrate intake in the 
control group (296.79 ±77.45 gram) was higher than the 
treatment group (276.42 ±35.50 gram), but the 
independent sample test showed no difference in 
carbohydrate intake before the inter-group study (p = 0.29) 
so that carbohydrate intake before the study did not 
become a confounding variable. 
 Nutrient intake data subject control and treatment groups 
during the study are presented in Table 3. Table 3 Based 
on average energy intake in the control group  
(1924.35 ±218.62 kcal) is higher than that of the treatment 
group (1883.81 ±187.89 kcal), independent sample test 
showed that there were no significant differences in energy 
intake between groups (p = 0.53) so that energy intake was 
not a confounding variable in the study. The mean protein 
intake in the control group (p = 0.53) was higher than the 
treatment group (96.21 ±10.93 gram), the independent 
sample test showed no significant differences in protein 
intake between groups (p = 0.53) so that protein intake is 
not a confounding variable in the study. The mean fat 
intake in the control group (42.76 ±4.85 grams) was higher 
than the treatment group (41.86 ±4.17 grams), the 
independent sample test showed no significant difference 
in fat intake between groups (p = 0.53) so that fat intake 
does not become a confounding variable in the study. The 
mean carbohydrate intake in the control group  
(288.611 ±32.75 grams) was higher than the treatment 
group (282.54 ±28.16 grams), the independent sample test 
showed no significant difference in carbohydrate intake 
between groups (p = 0.53) so that carbohydrate intake is 
not a confounding variable in the study.  
 Table 4 shows the levels of hsCRP before and after the 
intervention. In the control group, the mean hsCRP level 
before the intervention was  7.31 ±0.75 mg.L-1 whereas 
after the intervention the mean hsCRP level became  
5.65 ±0.88 mg.L-1. In the treatment group, the mean 
hsCRP level before intervention was 5.63 ±1.23 mg.L-1, 
whereas after the intervention was 3.69 ±1.35 mg.L-1. 
There was a significant difference between the mean levels 
of hsCRP before and after the intervention in the two 
groups (p = 0.00; p = 0.00). The mean hsCRP level before 
the intervention in the control group (7.31 ±0.75 mg.L-1) 
was higher than the treatment group (5.63 ±1.23 mg.L-1), 
there was a significant difference to the average hsCRP 
level before the intervention between the two group  
(p = 0.00). The mean hsCRP level after intervention in the 
control group (5.65 ±0.88 mg.L-1) was higher than the 
treatment group (3.69 ±1.35 mg.L-1),  there was a 
significant difference to the average hsCRP level after the 
intervention between the two group (p = 0.00). There was 
a significant difference in the decrease in hsCRP levels 
after the intervention in both groups (p = 0.03). 
 In this study, the mean hsCRP level in the treatment 
group decreased by 1.94 ±0.29 mg.L-1. This shows that 
giving as much as 150 grams of Tempeh gembus per day 
for 28 days is effective in reducing levels of hsCRP. The 
decrease in hsCRP levels in the treatment group can be 
caused by the presence of fiber in Tempeh gembus. Low 
fiber intake can increase proinflammatory cytokines IL-6), 
TNF-α, and IL-18. Increasing IL-6 can consistently 
increase CRP levels. High fiber intake can reduce fat 
oxidation resulting in decreased inflammation. Fiber is a 
protective factor to counter increasing CRP levels (Ma et 
al., 2006). Other studies have shown that fiber in 
fermented soybeans can reduce cholesterol levels so that it 
contributes positively to the anti-inflammatory effect. The 
fiber in fermented soybean consists of several 
monosaccharides including glucose, arabinose, galactose, 
and uronic acid which are components of cellulose and 
non-cellulose polysaccharides. The main non-cellulose 
polysaccharide from soybean fiber is arabinogalactant. The 
positive effect on the anti-inflammatory effect can be seen 
significantly in decreasing the levels of C-Reactive Protein 
(Kim et al., 2014). 
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 Besides fiber, Tempeh gembus also contains antioxidants 
in the form of isoflavones (daidzein and genistein) and 
unsaturated fatty acids (oleic, linoleic and linolenic fatty 
acids) which include essential fatty acids (Sulchan and 
Endang 2007; Sulchan and Rukmi 2007). The anti-
inflammatory mechanism by isoflavones is carried out by 
inhibiting the NF-kB transcription system and modulating 
arachidonic acid (AA) metabolism and Nitric Oxide (NO) 
production by inhibiting protein levels and the activity of 
proinflammatory enzymes (phospholipase A2 (PLA2), 
lipoxygenase (LOX, COX-2, and iNOS) (Jie et al., 2016). 
This study is in line with other studies that show that 
interventions with soy-based foods can reduce high 
sensitivity levels of C-Reactive Protein by 25% (Kone, 
2014). Apart from isoflavones, antioxidant activity 
Tempeh gembus probably derived from amino 
acids/peptides bioactive. Tempeh gembus containing 
amino acids such as tyrosine, methionine, histidine, lysine, 
cysteine and tryptophan. Activity of antioxidants in 
soybean gembus with ABTS method was 63.14 ±1.16% 
(Agustina et al., 2018). 
 Table 5 shows data on HDL levels before and after the 
intervention. In the control group, the mean HDL level 
before the intervention was 29.25 ±5.05 mg.dL-1 whereas 
after the intervention the mean HDL level was  
35.45 ±3.79 mg.dL-1. In the treatment group, the mean 
HDL level before the intervention was  
32.50 ±5.62 mg.dL-1 whereas after the intervention the 
average HDL level was 41.90 ±2.73 mg.dL-1. There was a 
significant difference between the mean HDL levels before 
and after the intervention in the two groups (p = 0.00;  
p = 0.00). The mean HDL levels before the intervention in 
the control group (29.25 ±5.05 mg.dL-1) were lower than 
the treatment group (32.50 ±5.62 mg.dL-1), there were no 
significant differences in the mean HDL levels before the 
intervention between both groups (p = 0.06). The mean 
HDL levels after the intervention in the control group 
(35.45 ±3.79 mg.dL-1) were lower than the treatment group 
(41.90 ±2.73 mg.dL-1), there were significant differences 
in the mean HDL after the intervention between the two 
groups (p = 0.00). There was a significant difference in the 
increase in HDL levels after the intervention in both 
groups (p = 0.00). In this study, the mean HDL levels in 
the treatment group increased by 9.40 ±4.48 mg.dL-1. The 
provision of 150 grams of processed Tempeh gembe for 28 
days is effective in increasing HDL levels in the treatment 
group. 
 The main content of Tempeh gembus is fiber. High fiber 
intake can increase the excretion of bile acids and 
cholesterol through feces thereby reducing bile acids to get 
back into the liver. The reduction of bile acids to the liver 
causes an increase in the use of cholesterol to bile acids so 
that it has an effect on increasing HDL (Buse, Kenneth 
and Harles, 2017). Besides fiber, the increase in HDL 
levels in the treatment group was due to the presence of 
flavonoids in Tempeh gembus. Flavonoids can increase the 
amount of Apolipoprotein A-1. Apolipoprotein A-1 acts as 
an enzyme cofactor for LCAT and as a ligand of 
interaction with lipoprotein receptors in tissues in HDL. 
An increase in Apolipoprotein A-1 is expected to increase 
HDL levels (Gropper, Smith, and Groff, 2012). 
According to the American Association of Clinical 
Endocrinologists (AACE, 2012) HDL levels of  
60 mg.dL-1 can reduce the risk of coronary heart disease 
(Jellinger et al, 2012). However, in this study there were 
no respondents with HDL levels reaching 60 mg.dL-1 after 
the intervention. Increased levels of HDL that do not reach 
optimal values are caused by several factors, one of which 
is exercise (Whitney and Sharon, 2015). Other studies 
have shown that adult women who exercise regularly, such 
as aerobic exercise three times a week, can experience 
increased levels of HDL (Wang and Peng, 2011). WHO 
states that aerobic exercise performed by adults aged 18-64 
years with moderate intensity for 150 minutes/week or 
high intensity for 75 minutes/week can increase HDL 
levels and be beneficial for heart health (WHO, 2011). 
Regular exercise can improve the work function of 
Apolipoprotein A-1 as an HDL receptor in reducing 
cholesterol from blood vessel walls (Kingwell and 
Michael, 2013). In this study, respondents only did 
aerobics once a week so this might be the cause of HDL 
cholesterol levels not reaching optimal values. In addition 
to lack of exercise, respondents' physical activity is also 
included in the mild category. The types of activities most 
frequently carried out by respondents were sleeping, 
watching TV, sweeping, washing clothes, cooking and 
making batik.  
 Changes in HDL and hsCRP levels also occurred in the 
control group. This is presumably due to the provision of 
restriction of food intake through a low calories diet of  
30 calories per kg body weight/day in the control group. 
Based on the results of the study, it is known that the 
control group's diet before the intervention was  
2306.96 kcal while during the intervention it decreased to 
1924.35 kcal. 
 Changes in calorie intake resulted in an increase in HDL 
levels of 6.20 ±2.35 mg.dL-1, from 29.25 ±5.05 mg.dL-1 to 
35.45 ±3.79 mg.dL-1. Foods that have been consumed will 
undergo metabolic processes and produce energy in the 
form of adenosine triphosphate (ATP) to carry out physical 
activity (Rodwell et al., 2018). When doing physical 
activity, energy needs will increase, so if glucose as the 
main energy source is insufficient there will be an increase 
in fat metabolism. This causes a decrease in body fat 
percentage and an increase in HDL cholesterol (Whitney 
and Sharon, 2015). Research on obese subjects shows that 
food intake restrictions affect changes in lipid profile, 
including increased levels of HDL (Fothergill et al., 
2016). Food intake restrictions are also able to protect 
against age-related diseases including inflammation by 
reducing oxidative stress (Omodei and Luigi, 2011; 
Rebrin, Michael and Rajindal, 2011). 
 Interventions in the form of limiting food intake in the 
control group also resulted in a decrease in hsCRP levels 
of 1.65 ±0.57 mg.L-1, from 7.31 ±0.75 mg.L-1 to  
5.65 ±0.88 mg.L-1. A decrease in subject's hsCRP levels 
can be caused by a decrease in fat intake. It is known that 
the mean fat intake in the control group before the 
intervention is 86.58 ±31.84 grams to 42.76 ±4.85 grams 
after the intervention. Fat intake is excessive will affect 
visceral fat to express a response to various stimuli one of 
them is an increase in spending of free fatty acids by 
adipose tissue that can stimulate increased secretion of 
VLDL in the liver which in turn will result in an increase 
in triglycerides, LDL and decrease HDL (Gropper, Smith 
and Groff, 2012; Wang and Peng, 2011). This increase 
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will trigger the release of HDL from the liver to carry 
cholesterol in the circulation (reverse cholesterol 
transport).  
HDL is esterified into cholesterol esters which can be 
directly carried to the liver to be directly excreted or 
exchanged with triglycerides from VLDL and 
chylomicrons. When cholesterol esters are excessive, 
triglyceride-rich HDL (low density HDL) is broken down 
by hepatic lipase, thus reducing circulating HDL levels. 
 As the result the reverse cholesterol transport process is 
reduced and cholesterol levels in the circulation and tissue 
increase (Murray, Granner and Rodwell, 2017). In one 
condition, an increase in excess cholesterol levels in the 
circulation causes an abnormal reaction that causes the 
activation of the scavenger macrophage. This macrophage 
is responsible for cleaning cholesterol and low-density 
 Tabel 1 Respondent Characteristics. 
Respondent 
Characteristics 
 Control Group Treatment Group  
 Mean ±SD Median Min-Max Mean ±SD Median Min – Max p 
Age (years)  35.05 ±8.54 34.00 21 – 50 36.50 ±9.37 39.00 21 – 48 0.64* 
Body Mass Index 
(kg.m-2) Before 30.00 ±5.61 28.40 25.10 – 47.67 28.22 ±2.49 27.73 25.08 – 33.23 0.51* 
Body Mass Index  
(kg.m-2) After 29.63 ±5.42 27.99 25.00 – 47.03 27.32 ±2.50 27.14 24.15 – 32.47 0.16* 
Level of physical 
activity (unit) During 1.52 ±0.17 1.42 1.40 – 1.79 1.48 ±0.10 1.43 1.40 – 1.73 0.84* 
Note: * Mann Whitney test. 
 
 
 Table 2 Diet Before Research. 
Respondent 
Characteristics 
Control Group Treatment Group  
Mean ±SD Median Min – Max Mean ±SD Median Min-Max p 
Energy (kcal) 2306.96 ±545.24 2284.65 916.40 – 3328.10 2057.70 ±241.06 1954.68 1823.6 – 2714.50 0.01* 
Protein(grams) 84.86 ±19.08 87.90 45.90 – 118.40 72.59 ±19.16 71.65 39.50 – 111.30 0.04** 
Fat (grams) 86.58 ±31.84 82.55 26.90 – 131.30 60.57 ±18.75 59.41 30.80 – 109.00 0.00** 
Carbohydrate 
(grams) 296.79 ±77.45 289.90 122.00 – 451.10 276.42 ±35.50 274.33 216.80 – 364.70 0.29** 
Note: * Mann Whitney test; ** independent sample test. 
 
 
 Table 3 Nutrition Intake During Research. 
Respondent 
Characteristics 
Control Group Treatment Group 
Mean ±SD Median Min – Max Mean ±SD Median Min – Max p 
Energy (kcal) 1924.35 ±218.62 1955.07 1456.65 – 2457.00 1883.81 ±187.89 1895.40 1512.81 – 2299.05 0.53** 
Protein(grams) 96.21 ±10.93 97.75 72.83 – 122.85 94.19 ±9.39 94.77 75.64 – 114.95 0.53** 
Fat (grams) 42.76 ±4.85 43.45 32.37 – 54.60 41.8 6 ±4.17 42.12 33.62 – 51.09 0.53** 
Carbohydrate 
(grams) 288.61 ±32.75 293.26 218.50 – 368.55 282.54 ±28.16 284.31 226.92 – 344.86 0.53** 
Tempeh 
Gembus (%) 0.00 ±0.00 0.00 0.00 – 0.00 61.37 ±19.05 56.88 35.88 – 94.90 0.00** 
Note: ** independent sample test. 
 
 
 Table 4 hsCRP levels before and after the intervention. 
hsCRP levels 
(mg.L-1) 
Control Group (n = 20) Treatment Group (n = 20) p Mean ±SD Median Min – Max Mean ±SD Median Min – Max 
Pre Intervention 7.31 ±0.75 7.15 6.20 – 8.90 5.63 ±1.23 5.35 4.40 – 9.30 0.00* 
Post Intervention 5.65 ±0.88 5.60 4.40 – 7.30 3.69 ±1.35 3.40 2.40 – 7.70 0.00* 
∆ 1.65 ±0.57 1.55 2.90 – 0.20 1.94 ±0.29 2.00 2.40 – 1.00 0.03* 
p 0.00*** 0.00 ***  
Note : p-value <0.05 = significant; * Mann Whitney test; *** Wilcoxon. 
 
Table 5 HDL levels before and after the intervention. 
HDL levels 
(mg/dL) 
Control Group (n = 20) Treatment Group (n = 20) p Mean ±SD Median Min – Max Mean ±SD Median Min – Max 
Pre Intervention 29.25 ±5.05 29.00 20.00 – 38.00 32.50 ±5.62 34.00 21.00 – 39.00 0.06** 
Post Intervention 35.45 ±3.79 36.00 27.00 – 42.00 41.90 ±2.73 42.00 36.00 – 47.00 0.00** 
∆ 6.20 ±2.35 6.00 2.00 – 10.00 9.40 ±4.48 8.00 2.00 – 20.00 0.00** 
P 0.00**** 0.00 ****  
Note p-value <0.05 = significant; ** independent sample test; **** paired t test. 
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HDL from circulation by phagocytosis. Macrophages that 
are full of cholesterol will then become foam cells that 
cause activation of pro-inflammatory cytokines (IL-1, IL-
6, and TNF α). Activation of pro-inflammatory cytokines 
is an early sign of inflammation. Continued inflammation 
will cause CRP expenditure from the liver (Pitsavos et al., 
2006). Other studies have shown that low fat intake can 
inhibit cytokine release and reduce levels of hsCRP in the 
blood (Camhi et al., 2010). This is due to adipose tissue 
reducing the expenditure of free fatty acids causing a 
decrease in total cholesterol, LDL, triglyceride levels and 
an increase in HDL that affect macrophages, thereby 
impacting on decreasing hsCRP levels (Murray, Granner 
and Rodwell, 2017). 
 Intervention in the form of limiting long-term food intake 
has a very strong protective effect on the risk of 
atherosclerotic cardiovascular disease (CVD) as evidenced 
by a decrease in blood pressure, LDL cholesterol, hsCRP, 
IL-6, TNF-α, and an increase in HDL cholesterol levels 
(Dolinsky and Dyck, 2011). Restricted food intake has 
been shown to improve mitochondrial function, reduce 
oxidative stress and increase nitric oxide production 
involved in the prevention of atherosclerosis, reduction in 
blood pressure, weakening of left ventricular hypertrophy, 
resistance to myocardial ischemic injury and prevention of 
heart failure (Weiss and Luigi, 2011). 
 
CONCLUSION 
 The administration of processed Tempeh gembus for  
28 days can reduce high sensitivity c-reactive protein 
(hsCRP) by 1.93 mg.L-1 and increase HDL levels by  
9.40 mg.dL-1 in obese women in penitentiary class II 
Semarang city, Indonesia. Changes in hsCRP and HDL 
levels also occurred in the control group. This is thought to 
be due to a standard diet of 30 calories/kg body weight/day 
for 28 days. 
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